Clinical trial reportHead & neckPublished
Safety and Efficacy Findings From a Phase Ib/II Study of ASP-1929 Photoimmunotherapy With Pembrolizumab in Recurrent and/or Metastatic Head and Neck Squamous Cell Carcinoma
Regional connection
Verified An author affiliation on the Europe PMC record names Thomas Jefferson University. Affiliation source
- Institution
- Thomas Jefferson University
- County
- Philadelphia County
Publication record
- Type
- Clinical trial report
- Venue
- Head & neck
- Published
- Topic
- Clinical care
- Subject terms
- Humans; Head and Neck Neoplasms; Neoplasm Recurrence, Local; Treatment Outcome; Immunotherapy; Phototherapy; Adult; Aged; Middle Aged; Female; Male; Antibodies, Monoclonal, Humanized
- PubMed ID
- 40852760
- PubMed Central ID
- PMC12703558
- Open access
- Yes, open
- Added to directory
- Source checked